Brukinsa
Brand Name: Brukinsa
Generic Name: Zanubrutinib
Active
Registration Number
DR-XY48345
Dosage Form
Capsule
Issuance Date
September 8, 2022
Expiry Date
September 8, 2027
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength80 mg
Packaging200 cc round, white HDPE bottle (with 38/400 white polypropylene child-resistant closure with induction seal liner) x 120's (box of 120's
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Bruton's Tyrosine Kinase (BTK) Inhibitor
A
Application
Monitored Release
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
ZanubrutinibActive
Monograph: Zanubrutinib